All
Genomic Analysis Points to More Effective Treatment Options in Lymphoma Subtype
May 15th 2018Thanks to genomic analysis by scientists at the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard, diffuse large B cell lymphoma (DLBCL) is now a little easier to understand – and possibly easier to treat.
Why Are Survivorship Care Plans Not Being Received?
May 12th 2018The transition into survivorship is no easy feat. Emotions are mixed, long-term and late side effects may kick in and follow-up care appointments start. But are survivors getting the best possible care after cancer treatment? That’s still up for debate.